Overview
Lisa Ahrendt is a Hematologist and a Hematologist Oncology provider in Denver, Colorado. Dr. Ahrendt has been practicing medicine for over 29 years and is rated as an Experienced provider by MediFind in the treatment of Factor V Leiden Thrombophilia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Ahrendt is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1825 North Marion Street, Denver, CO 80218
1825 North Marion Street, Denver, CO 80218
Rocky Mountain Cancer Centers LLP
Robert Jotte is a Hematologist and an Oncologist in Denver, Colorado. Dr. Jotte is rated as a Distinguished provider by MediFind in the treatment of Factor V Leiden Thrombophilia. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Jotte is currently accepting new patients.
Rocky Mountain Cancer Centers LLP
Mark Sitarik is an Oncologist in Boulder, Colorado. Dr. Sitarik is rated as a Distinguished provider by MediFind in the treatment of Factor V Leiden Thrombophilia. His top areas of expertise are Von Willebrand Disease (VWD), Heyde Syndrome, Paget Disease of the Breast, and Breast Cancer. Dr. Sitarik is currently accepting new patients.
Intermountain Medical Group Denver LLC
Karng Log is a Hematologist Oncology specialist and a Hematologist in Firestone, Colorado. Dr. Log is rated as a Distinguished provider by MediFind in the treatment of Factor V Leiden Thrombophilia. His top areas of expertise are Waldenstrom Macroglobulinemia, Colorectal Cancer, Acute Intermittent Porphyria, and Familial Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AngiosarcomaDr. Ahrendt isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Ahrendt isAdvanced. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Ahrendt isAdvanced. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Ahrendt isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Acute Mountain SicknessDr. Ahrendt isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Ahrendt isExperienced. Learn about Adult Immune Thrombocytopenia.
- Anal CancerDr. Ahrendt isExperienced. Learn about Anal Cancer.
- AnemiaDr. Ahrendt isExperienced. Learn about Anemia.
- Antiphospholipid SyndromeDr. Ahrendt isExperienced. Learn about Antiphospholipid Syndrome.
- BRCA Positive Breast CancerDr. Ahrendt isExperienced. Learn about BRCA Positive Breast Cancer.